Overview of Dr. O'Shea
Dr. Sarah O'Shea is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from University of Illinois College of Medicine at Chicago and has been in practice 5 years. She also speaks multiple languages, including Spanish. She specializes in movement disorder and dementia & geriatrics and is experienced in deep brain stimulation, movement disorders, parkinson's disease, epidemiology, and botulinum toxin injections for movement disorders. She has more than 20 publications and over 150 citings.
Office
710 West 168th Street
New York, NY 10032
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Neuromuscular Medicine (Neurology), 2016 - 2019
- Columbia University MS, Epidemiology, 2016 - 2018
- University of Iowa Hospitals and ClinicsResidency, Neurology, 2012 - 2016
- University of Illinois College of MedicineClass of 2012
Certifications & Licensure
- NY State Medical License 2016 - 2025
- MA State Medical License 2019 - 2023
- IA State Medical License 2012 - 2016
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease Start of enrollment: 2020 Feb 27
Publications & Presentations
PubMed
- 23 citationsNeurogenetic disorders across the lifespan: from aberrant development to degeneration.Richard A Hickman, Sarah A O'Shea, Mark F Mehler, Wendy K Chung
Nature Reviews. Neurology. 2022-02-01 - 74 citationsMultimodal deep learning for Alzheimer's disease dementia assessment.Shangran Qiu, Matthew I Miller, Prajakta S Joshi, Joyce C Lee, Chonghua Xue
Nature Communications. 2022-06-20 - 31 citationsMyoclonus in Patients With Coronavirus Disease 2019: A Multicenter Case Series.Pria Anand, Asma Zakaria, Karima Benameur, Charlene Ong, Maryann Putman
Critical Care Medicine. 2020-01-01
Abstracts/Posters
- Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage.Bird K, Saint-Hilaire M, Curiale G, O'Shea SA., The International Parkinson and Movement Disorder Society (MDS) Congress., Virtual, 2020
- The Accreditation and Certification of the Movement Disorders Subspecialty: A Five- Year Follow-Up Study.S. O’Shea, L. Guttmann, L. Faulkner., The International Parkinson and Movement Disorder Society (MDS) Congress., Virtual, 2020
- Prenatal Exposure to Chlorpyrifos and Parkinson’s risk: a prospective adolescent cohort evaluation.O’Shea SA, Alcalay R, Rauh V., American Academy of Neurology (AAN), Los Angeles, CA, 2018
- Join now to see all
Press Mentions
- Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's DiseaseJune 9th, 2016
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: